5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

Intrauterine Resuscitation Bundle & Clinical Interventions

When faced with a Category II indeterminate or Category III abnormal tracing, the CNM immediately executes the evidence-based intrauterine resuscitation algorithm:

1. Maternal Repositioning: Turn the patient to the full left or right lateral decubitus position. This relieves aortocaval compression by the gravid uterus, improves maternal venous return and stroke volume, and optimizes uterine arterial perfusion. If cord compression is suspected, try hands-and-knees positioning.
2. Discontinue Uterotonic Agents: Immediately stop oxytocin infusions or remove dinoprostone vaginal inserts to eliminate myometrial hyperstimulation and restore intervillous blood flow.
3. Intravenous Fluid Bolus: Rapidly infuse 500 to 1,000 mL of Lactated Ringer's solution. Intravascular volume expansion elevates maternal cardiac output and increases placental perfusion pressure.
4. Correct Maternal Hypotension: If hypotension develops following neuraxial analgesia, administer vasopressors per protocol (ephedrine 5–10 mg IV or phenylephrine 50–100 mcg IV) alongside fluid boluses.
5. Uterine Tocolysis for Tachysystole: If uterine tachysystole (>5 contractions in 10 minutes averaged over 30 minutes) occurs with FHR decelerations and fails to resolve after stopping oxytocin, administer terbutaline 0.25 mg subcutaneously. Terbutaline relaxes myometrial smooth muscle within 2 to 3 minutes, halting contractions and restoring placental perfusion.
6. Supplemental Oxygen Administration: Administer oxygen at 10 L/min via a non-rebreather face mask. Note: Modern guidelines advise against routine prophylactic oxygen for Category I or uncomplicated tracings, as hyperoxia generates reactive oxygen species. Supplemental oxygen is reserved specifically for maternal hypoxemia or refractory Category II/III tracings failing positional and fluid maneuvers.
7. Amnioinfusion: For recurrent, severe variable decelerations unresponsive to maternal repositioning, infuse warmed isotonic normal saline via an intrauterine pressure catheter (IUPC) (bolus of 250–500 mL over 30 minutes, followed by maintenance infusion of 100–150 mL/hr). Amnioinfusion restores amniotic fluid cushion volume, directly relieving mechanical umbilical cord compression.
8. Fetal Scalp Stimulation: During periods of baseline with absent or minimal variability without decelerations, perform digital stroking of the fetal scalp for 15 seconds through the open cervix. Eliciting an acceleration of ≥ 15 bpm for ≥ 15 seconds provides an immediate, 99% reliable correlation that the fetal scalp pH is ≥ 7.20 (excluding metabolic acidemia). Caution: Never perform scalp stimulation during an active deceleration.

Internal Monitoring: The Fetal Spiral Electrode

A fetal spiral (scalp) electrode (FSE) screws a small wire into the fetal scalp and records the fetal electrocardiogram directly, producing the most accurate available assessment of rate and, critically, of variability.

Prerequisites: ruptured membranes, cervical dilation of roughly 2–3 cm or more, and a presenting part that is accessible and definitively identified — placing an electrode on a face, fontanelle, or genitalia causes real injury.

Indications: an external tracing that cannot be reliably obtained (maternal habitus, maternal movement, fetal position), or the need to distinguish the maternal heart rate from the fetal heart rate when the external signal is ambiguous.

Contraindications:

• Maternal HIV, hepatitis B, or hepatitis C — invasive monitoring breaches the fetal skin barrier and raises vertical transmission risk.
• Active genital herpes lesions.
• Suspected fetal bleeding disorder or thrombocytopenia (including alloimmune thrombocytopenia).
• Placenta previa or unknown placental location, and face presentation.
• Known or suspected fetal anomaly at the presenting part.

Complications: scalp laceration and bleeding, scalp abscess, and — rarely — osteomyelitis or cerebrospinal fluid leak.

---

Amnioinfusion

Amnioinfusion instills warmed isotonic fluid into the amniotic cavity through an IUPC to restore the fluid cushion around the umbilical cord.

Indication: recurrent variable decelerations attributed to cord compression that persist after maternal repositioning. It is also used for oligohydramnios with cord compression.

[!IMPORTANT] Amnioinfusion is not recommended as routine prophylaxis for meconium-stained amniotic fluid. Large randomized trials showed no reduction in meconium aspiration syndrome or perinatal death when it was used for that indication alone.

Technique:

1. Place an IUPC and document baseline resting tone.
2. Infuse warmed normal saline or lactated Ringer's: a bolus of 250–500 mL over 20–30 minutes, then a maintenance infusion of about 100–180 mL/hour.
3. Track total volume infused and total returned. Fluid must drain; if output stops, stop the infusion.
4. Reassess the fetal heart rate pattern, resting tone, and maternal temperature continuously.

Contraindications: a fetal heart rate pattern requiring immediate delivery, clinical intraamniotic infection, polyhydramnios, known uterine anomaly, placenta previa, and any contraindication to IUPC placement.

Complications: uterine overdistension with elevated resting tone, prolonged decelerations during the bolus, cord prolapse, infection, and — rarely — uterine rupture in a scarred uterus.

Internal Monitoring: The Intrauterine Pressure Catheter

The fetal spiral electrode answers "what is the fetal heart doing?" The intrauterine pressure catheter (IUPC) answers the separate question "how much work is the uterus doing?" — and the two are placed for different reasons.

• Prerequisites are the same as for the spiral electrode: ruptured membranes, adequate cervical dilation, and a presenting part that has been definitively identified.
• Indications: assessment of labor adequacy when progress has arrested and the external tocodynamometer cannot quantify contraction strength (most often with maternal obesity), titration of oxytocin against measured rather than inferred uterine activity, and delivery of an amnioinfusion.
• Contraindications: placenta previa or unexplained bleeding, active genital infection, and any situation in which immediate delivery is indicated.
• Complications: placental abruption or vessel perforation on insertion, infection, and — rarely — uterine perforation. An IUPC is also the only route by which quantified uterine work (Montevideo units, covered with uterine activity assessment) can be obtained.

Escalation, Documentation & Communication

A resuscitation bundle that works clinically still fails the patient if it is not communicated. The intrapartum standard of care has two parts, and the second is tested as often as the first:

1. Document the tracing, not a conclusion. Record baseline rate, variability, the presence and type of accelerations and decelerations, and uterine activity — then the NICHD category, then the interventions performed, then the fetal response to those interventions. "Reassuring" is not documentation; a category assignment with its four supporting elements is.
2. Escalate with a structured handoff. Use a defined format — situation, background, assessment, recommendation — and state explicitly what you are asking for and by when. "I need you at the bedside now" and "I am activating the cesarean team" carry different meanings and should never be left to inference.

Two further principles govern persistent Category II and any Category III tracing:

• A Category III tracing requires prompt evaluation and, if it does not resolve with the resuscitation bundle, expeditious delivery. Category III is not a waiting state.
• Persistent Category II demands an explicit plan with a time limit — the intervention chosen, the interval at which the response will be reassessed, and the action that follows if the tracing has not improved. Undocumented, open-ended observation of a Category II tracing is the most common failure mode in intrapartum litigation.